Clinical research organisation (CRO) ProTrials Research has selected eClinical and regulatory solutions and services provider Calyx as the approved partner to boost clinical trial outcomes data.
Through the collaboration, Calyx will expand its established interactive response technology (IRT), medical imaging, electronic data capture (EDC) solutions and services to aid global clients of ProTrials attain clinical development goals.
Clients of ProTrials will use the new technology of Calyx to enhance the clinical trial outcomes data. This eventually enables them to offer safe medical therapeutics to patients.
ProTrials focuses on offering clinical operations services to the pharmaceutical, biotechnology and medical device sectors.
The company provides trial management, grant services, investigative site monitoring and linked clinical development services, among others.
ProTrials Research Quality Assurance director Christy Meyer said: “We’re pleased to partner with Calyx and are confident that our customers will benefit from the scientific, medical, and clinical expertise they have honed during their 30 years of delivering reliable eClinical solutions to the clinical development industry.”
Calyx has clinical development expertise and supports trial sponsors and CROs.
Leveraging intelligence and expertise in solving complicated problems, Calyx provides rapid insights and aids in bringing new therapies to market.
Calyx Technical Solutions vice-president Elizabeth Dalton said: “We look forward to delivering the important imaging and eClinical data ProTrials’ customers rely on as they evaluate the safety and efficacy of often life-saving medical treatments.
“We’re honoured that ProTrials selected Calyx to support them as they deliver on their commitment to improve the health and extend the lives of patients worldwide.”